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Background
Skin is the most commonly affected organ by adverse
drug reactions in almost 30% of all cases. According to
the international consensus on drug allergy, drug hyper-
sensitivity reactions (DHRs) constitute 15% of all
adverse drug reactions affecting more than 7% of the
general population.
Methods
Herein we present case series of various non-immediate
DHRs (occurring at any time as from 1 hour after the
initial drug administration) amongst which drug-related
intertriginous and flexural exanthema (Baboon syndrome),
DRESS syndrome, fixed drug eruption and contact derma-
titis. In all cases we performed patch testing with standar-
dized and allergens prepared at our laboratory with the
suspected drugs. The timing of patch test procedure was
in median 6 weeks after the resolution of skin changes.
Results
Based on the patch test results, we comment on the
sensitivity and specificity of patch test in non-immediate
DHRs. Different variables influence patch testing in
DHRs such as allergen preparation, vehicle, concentra-
tion, intake of certain medications and testing healthy
controls with the suspected allergens. We emphasize on
these and on the demand for control and interpretation
of the results. The role of web drug allergen databases
in preparation of proper drug concentration and vehicle
for patch testing is reviewed.
Conclusions
This presentation reports the personal experience with in
vivo skin patch testing in patients with non-immediate
DHRs.
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